Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
934.6 DKK | -3.64% |
|
-4.22% | +33.93% |
08:13am | Roche reports positive early results in obesity drug trial | RE |
06:31am | Dutch Health Care Wary of Reimbursing Novo Nordisk's Obesity Drug Cost | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.93% | 627B | |
+61.53% | 848B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+11.21% | 234B | |
+15.38% | 225B | |
+15.67% | 179B | |
+2.47% | 167B | |
+2.03% | 125B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Transcript : Novo Nordisk A/S Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 06